Histological and qPCR analyses revealed that CYP2E1 inhibition alleviated hepatic steatosis, inflammation, and fibrosis in USP14-overexpressing mice (Fig. 7H–J; Fig. S7E). This evidence concerns the gene CYP2E1 and Hepatic steatosis.